RecruitingNCT03807687

Registry of Pancreatic Disease

Registry of Subjects Affected by Pancreatic Disease and Evaluated at the Pancreas Institute of Verona

Sponsor

Azienda Ospedaliera Universitaria Integrata Verona

Enrollment

3,000 participants

Start Date

Dec 1, 2016

Study Type

OBSERVATIONAL

Conditions

Pancreatic Neoplasms Pancreatitis Pancreatic Diseases

Summary

This clinical data registry records information about the health status and healthcare performances received by participants affected by every type of pancreatic disease or disorder. All data (demographic, clinical, biochemical, radiological, pharmacological, genetic...) and audio and/or video recording from operative room are collected in order to be used for prospective or retrospective studies.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is building a large medical registry (a database that collects information from many patients over time) for people with any type of pancreatic disease — including pancreatitis (inflammation of the pancreas), pancreatic cysts, and pancreatic cancer — to improve doctors' understanding of these conditions and lead to better treatments in the future. **You may be eligible if...** - You have been diagnosed with any type of pancreatic disease, whether it is inflammatory (such as acute or chronic pancreatitis) or involves a growth in the pancreas (including solid tumors, cysts, or other lesions) - You are physically and mentally able to give your consent to participate - There is no age restriction mentioned for this registry **You may NOT be eligible if...** - You are unable to give informed consent due to a physical or mental condition that prevents you from understanding or agreeing to participate in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.